Clinical
Trials
If you are a patient or health care provider who would like more information about a clinical trial, please contact our research team.
If you are a patient or health care provider who would like more information about a clinical trial, please contact our research team.
-
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Lung Cancer
Condition:
Lung Cancer
Molecule:Tislelizumab
-
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma
Condition:
Gastric Cancer, Esophageal Cancer
Molecule:Tislelizumab
-
A Study of Tislelizumab as Monotherapy in Relapsed or Refractory Classical Hodgkin Lymphoma
Condition:
Lymphoma
Molecule:Tislelizumab
-
BGB-A317-002 [No Study Record]
Condition:
Advanced solid tumors
Molecule:Tislelizumab
-
Study of the Safety, Pharmacokinetics and Antitumor Activities of Tislelizumab in Subjects With Advanced Tumors
Condition:
Advanced solid tumors
Molecule:Tislelizumab
-
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Subjects With Newly Diagnosed or Recurrent Glioblastoma
Condition:
Glioblastoma
Molecule:Pamiparib + Radiotherapy and/or Temozolomide [1L] and Pamiparib + Temozolomide [R/R])
-
Study to Assess Safety, Tolerability and Clinical Activity of Pamiparib in Combination With Temozolomide (TMZ) in Subjects With Locally Advanced or Metastatic Solid Tumors
Condition:
Advanced solid tumors
Molecule:Pamiparib + Temozolomide
-
The Safety, Pharmacokinetics and Antitumor Activity of Tislelizumab in Combination With Pamiparib in Subjects With Advanced Solid Tumors
Condition:
Advanced solid tumors
Molecule:Tislelizumab + Pamiparib
-
Study of Pamiparib or Placebo in Patients With Advanced or Inoperable Gastric Cancer
Condition:
Gastric Cancer
Molecule:Pamiparib
-
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Trial of Maintenance Treatment With Pamiparib Versus Placebo in Patients With Platinum-sensitive Recurrent Ovarian Cancer
Condition:
Ovarian Cancer
Molecule:Pamiparib
See All Trials
Clinical trials are an important part of our research and development efforts and help make possible access to safe and potentially life-saving treatments.